Malaria epidemic threatened by greed

Illegal drug developers are exploiting one of the world’s most prevalent diseases by distributing fake anti-malaria drugs in the Asia-Pacific region. Malaria, a disease caused by parasites, transferred usually by the Anopheles mosquito causes high fever and eventually death, has no vaccine. Therefore, the treatments provided by drugs are pertinent to making sure the disease does not escalate.

When administered to a child one possible side effect of the fake drugs is death. Long term effects include distrust in the use of drugs and development of resistance to the active ingredient, artemisinin, which fights malaria, but in its minor dosage in the fake drug can be potentially harmful. Fake drug developers are staying one step ahead of enforcement agencies as they manufacture the drugs with this small amount of artemisinin in order to pass tests as though the drug were real (safe and effective). The poorly developed drugs may also have traces of carcinogens as well. Ric Price, Professor of Global Health at Darwin’s Menzies School of Health Research states that  “about 20%-60% of the drugs sold across the counter in Asia in many parts are usually fake.” Developing countries are falling into this trap because their limited budget to purchase medicines means that cheaper drugs are entering the country without a quality check and while countries like China have made some success at shutting down the illegal factories, other black markets are spreading in New Delhi and even Nigeria.

The problem is even more concerning as the Institute for Health Metrics and Evaluation (IHME) has found that it previously underestimated the number of malaria cases there are worldwide. Today, the number of people affected is approximately 1.2 million. Risk of developing resistance of artemisinin means that the progress made towards fully eradicating the disease can be jeopardized. An IHME study found that 76% of deaths related to malaria are from Asia alone.


  1. marinaerlikh said:

    The problem of counterfeit drugs is not a new one, nor is it strictly limited to developing nations in the Asia-Pacific region and the diseases prevalent there, such as Malaria. According to the FDA, several counterfeit cancer drugs have infiltrated the US pharmaceutical supply chain; these include Avastin (a drug used to treat colon cancer), Faslodex (breast cancer drug), and Rituxan (lymphoma drug). Some experts are calling for a “track and trace” system which would use bar-codes to identify and trace the “real” drugs, making it more difficult for counterfeits to bypass pharmaceutical security.

    The issue is one of greed, and greed does not discriminate. When counterfeiters see an opportunity to make money off of fake drugs, they seize it, irregardless of the fact that these drugs may cause irreparable damage to poor people in Southeast Asia suffering from Malaria or better-off Americans with cancer.

    Here is a link to the article about counterfeit cancer drugs:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: